← Open Payments lookup

MOSHE ROSE: Open Payments

NPI 1982765574 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 37 payments from 10 companies in 2025. Trend: 2023 $583 · 2024 $585 · 2025 $639

Food & beverage: $640
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.11$152
Otsuka America Pharmaceutical, Inc.11$139
Biogen, Inc.1$120
ABBVIE INC.4$70
Alkermes, Inc.4$63
E.R. Squibb & Sons, L.L.C.2$33
Vanda Pharmaceuticals Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16
Lundbeck LLC1$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: Qelbree, REXULTI, ZURZUVAE, VRAYLAR, ARISTADA, COBENFY, ABILIFY ASIMTUFII, FANAPT.

Industry payments across NJ — which companies pay providers there.